Evidence map›Paper›PMID 34001398›Full record

ArticleAnais brasileiros de dermatologia

Adverse events of the yellow fever vaccine in chronic urticaria: evaluation of patients treated or not with omalizumab compared to healthy individuals.

Laura Ramos de Almeida, Roberta Fachini Criado, Paulo Ricardo Criado, Luis Felipe Ensina, Beatrice Martinez Zugaib Abdalla, Juarez Antônio Simões Quaresma

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Anais brasileiros de dermatologia. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Laura Ramos de AlmeidaFaculty of Medicine, Centro Universitário Saúde ABC, Santo André, SP, Brazil.
Roberta Fachini CriadoFaculty of Medicine, Centro Universitário Saúde ABC, Santo André, SP, Brazil.
Paulo Ricardo CriadoFaculty of Medicine, Centro Universitário Saúde ABC, Santo André, SP, Brazil.
Luis Felipe EnsinaDivision of Allergy, Clinical Immunology and Rheumatology, Department of Pediatrics, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
Beatrice Martinez Zugaib AbdallaFaculty of Medicine, Centro Universitário Saúde ABC, Santo André, SP, Brazil. Electronic address: dra.beatrice.abdalla@gmail.com.
Juarez Antônio Simões QuaresmaCenter for Biological and Health Sciences, Universidade Estadual do Pará, Belém, PA, Brazil.
Faculdade de Medicina do ABC · BRUniversidade do Estado do Pará · BRUniversidade Federal de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Allergic AgentsChronic UrticariaUrticariaYellow Fever VaccineChronic DiseaseHumansOmalizumabTreatment OutcomeAnti-Allergic AgentsOmalizumabYellow Fever Vaccine

Identifiers

PMID34001398
PMCPMC8245712
OpenAlexW3160652905

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.